NAGA
Basic information
Region (hg38): 22:42058334-42070842
Links
Phenotypes
GenCC
Source:
- alpha-N-acetylgalactosaminidase deficiency type 2 (Definitive), mode of inheritance: AR
- alpha-N-acetylgalactosaminidase deficiency type 1 (Strong), mode of inheritance: AR
- alpha-N-acetylgalactosaminidase deficiency type 2 (Strong), mode of inheritance: AR
- alpha-N-acetylgalactosaminidase deficiency type 1 (Supportive), mode of inheritance: AR
- alpha-N-acetylgalactosaminidase deficiency type 2 (Supportive), mode of inheritance: AR
- alpha-N-acetylgalactosaminidase deficiency type 3 (Supportive), mode of inheritance: AR
- alpha-N-acetylgalactosaminidase deficiency type 1 (Strong), mode of inheritance: AR
- alpha-N-acetylgalactosaminidase deficiency (Definitive), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Kanzaki disease; Alpha-n-acetylgalactosaminidase deficiency; Schindler disease type I; Schindler disease type III | AR | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Biochemical; Dermatologic; Neurologic | 2564952; 2243144; 7707696; 8071745; 8040340; 8782044; 11313741; 11251574; 14685826; 15619430 |
ClinVar
This is a list of variants' phenotypes submitted to
- Alpha-N-acetylgalactosaminidase_deficiency_type_1 (303 variants)
- Inborn_genetic_diseases (43 variants)
- Alpha-N-acetylgalactosaminidase_deficiency_type_2 (36 variants)
- not_provided (35 variants)
- not_specified (12 variants)
- NAGA-related_disorder (7 variants)
- Alpha-N-acetylgalactosaminidase_deficiency (6 variants)
- Intellectual_disability (3 variants)
- Alpha-N-acetylgalactosaminidase_deficiency_type_3 (2 variants)
- Fetal_akinesia_deformation_sequence_1 (1 variants)
- Arthrogryposis_multiplex_congenita (1 variants)
- See_cases (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the NAGA gene is commonly pathogenic or not. These statistics are base on transcript: NM_000000262.3. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
---|---|---|---|---|---|---|
synonymous | 115 | 116 | ||||
missense | 87 | 97 | ||||
nonsense | 14 | 21 | ||||
start loss | 0 | |||||
frameshift | 10 | 13 | ||||
splice donor/acceptor (+/-2bp) | 9 | |||||
Total | 25 | 20 | 91 | 119 | 1 |
Highest pathogenic variant AF is 0.00364901
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
NAGA | protein_coding | protein_coding | ENST00000396398 | 9 | 12489 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
1.77e-11 | 0.116 | 125699 | 0 | 49 | 125748 | 0.000195 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.169 | 237 | 244 | 0.970 | 0.0000154 | 2723 |
Missense in Polyphen | 70 | 76.964 | 0.90952 | 861 | ||
Synonymous | 0.901 | 84 | 95.2 | 0.883 | 0.00000600 | 785 |
Loss of Function | 0.510 | 18 | 20.5 | 0.878 | 0.00000100 | 210 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000297 | 0.000297 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.0000544 | 0.0000544 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.000196 | 0.000193 |
Middle Eastern | 0.0000544 | 0.0000544 |
South Asian | 0.000458 | 0.000457 |
Other | 0.000653 | 0.000652 |
dbNSFP
Source:
- Function
- FUNCTION: Removes terminal alpha-N-acetylgalactosamine residues from glycolipids and glycopeptides. Required for the breakdown of glycolipids. {ECO:0000269|PubMed:9741689}.;
- Disease
- DISEASE: Schindler disease (SCHIND) [MIM:609241]: Form of NAGA deficiency characterized by early-onset neuroaxonal dystrophy and neurological signs (convulsion during fever, epilepsy, psychomotor retardation and hypotonia). NAGA deficiency is typically classified in three main phenotypes: NAGA deficiency type I (Schindler disease or Schindler disease type I) with severe manifestations; NAGA deficiency type II (Kanzazi disease or Schindler disease type II) which is mild; NAGA deficiency type III (Schindler disease type III) characterized by mild-to-moderate neurologic manifestations. NAGA deficiency results in the increased urinary excretion of glycopeptides and oligosaccharides containing alpha-N-acetylgalactosaminyl moieties. Inheritance is autosomal recessive. {ECO:0000269|PubMed:2243144, ECO:0000269|PubMed:8782044}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Kanzaki disease (KANZD) [MIM:609242]: Autosomal recessive disorder characterized by late-onset, angiokeratoma corporis diffusum and mild intellectual impairment. {ECO:0000269|PubMed:11251574, ECO:0000269|PubMed:8040340}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
- Pathway
- Lysosome - Homo sapiens (human);Glycosphingolipid biosynthesis - globo and isoglobo series - Homo sapiens (human);Glycosphingolipid biosynthesis - globoseries
(Consensus)
Recessive Scores
- pRec
- 0.394
Intolerance Scores
- loftool
- 0.257
- rvis_EVS
- -0.31
- rvis_percentile_EVS
- 32.06
Haploinsufficiency Scores
- pHI
- 0.338
- hipred
- N
- hipred_score
- 0.219
- ghis
- 0.559
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.0945
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Naga
- Phenotype
- homeostasis/metabolism phenotype; hematopoietic system phenotype; immune system phenotype;
Gene ontology
- Biological process
- oligosaccharide metabolic process;carbohydrate catabolic process;glycoside catabolic process;glycolipid catabolic process;glycosylceramide catabolic process
- Cellular component
- cytoplasm;lysosome;extracellular exosome
- Molecular function
- alpha-galactosidase activity;alpha-N-acetylgalactosaminidase activity;protein homodimerization activity